Peripheral compartment innate immune response to Haemophilus influenzae and Streptococcus pneumoniae in chronic obstructive pulmonary disease patients
暂无分享,去创建一个
K. Fong | I. Yang | R. Bowman | A. Semmler | M. Nataatmadja | J. Shaw | S. Francis | M. Tan | P. Fung
[1] L. Palmberg,et al. Chemokine release by neutrophils in chronic obstructive pulmonary disease , 2012, Innate immunity.
[2] J. Søndergaard,et al. Divergent Pro-Inflammatory Profile of Human Dendritic Cells in Response to Commensal and Pathogenic Bacteria Associated with the Airway Microbiota , 2012, PloS one.
[3] L. Edwards,et al. Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.
[4] Christopher E Brightling,et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. , 2011, American journal of respiratory and critical care medicine.
[5] G. Joos,et al. Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .
[6] J. Bengoechea,et al. Impact of cigarette smoke exposure on host–bacterial pathogen interactions , 2011, European Respiratory Journal.
[7] B. Cosío,et al. Mecanismos moleculares de inflamación durante las agudizaciones de la enfermedad pulmonar obstructiva crónica , 2011 .
[8] P. Gibson,et al. Innate Immune Responses Are Increased in Chronic Obstructive Pulmonary Disease , 2011, PloS one.
[9] Laszlo Nagy,et al. Chronic Obstructive Pulmonary Disease-Specific Gene Expression Signatures of Alveolar Macrophages as well as Peripheral Blood Monocytes Overlap and Correlate with Lung Function , 2011, Respiration.
[10] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[11] S. Sethi,et al. Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer , 2011, International journal of chronic obstructive pulmonary disease.
[12] A. Agustí,et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. , 2011, Archivos de bronconeumologia.
[13] J. Wedzicha,et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.
[14] L. Palmberg,et al. Altered innate immune response in farmers and smokers , 2010, Innate immunity.
[15] S. Salvi,et al. Year‐in‐review 2009: Asthma, COPD and airway biology , 2010, Respirology.
[16] J. Wedzicha,et al. Defective macrophage phagocytosis of bacteria in COPD , 2009, European Respiratory Journal.
[17] M. Decramer,et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial , 2009, The Lancet.
[18] Min Han,et al. Impact of Cigarette Smoke Exposure on Innate Immunity: A Caenorhabditis elegans Model , 2009, PloS one.
[19] J. Houwing-Duistermaat,et al. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study , 2009, BMC Medical Genetics.
[20] S. Diamond,et al. Neutrophil Isolation Protocol , 2008, Journal of visualized experiments : JoVE.
[21] D. Postma,et al. Airways inflammation and treatment during acute exacerbations of COPD , 2008, International journal of chronic obstructive pulmonary disease.
[22] F. Mihălțan,et al. Anti-TNF-alpha therapies in chronic obstructive pulmonary diseases. , 2008, Expert opinion on investigational drugs.
[23] B. Celli,et al. Impact of COPD exacerbations on patient-centered outcomes. , 2007, Chest.
[24] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[25] K. Heeg,et al. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. , 2006, Journal of periodontal research.
[26] S. Paludan,et al. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll‐like receptors 2, 4, and 9 in species‐specific patterns , 2006, Journal of leukocyte biology.
[27] P. Wallace,et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. , 2006, American journal of respiratory and critical care medicine.
[28] L. Fabbri,et al. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.
[29] A. Agustí,et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease , 2006, Respiratory research.
[30] G. Donaldson,et al. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation , 2005, Respiratory research.
[31] T. Seemungal,et al. Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD , 2005, Chest.
[32] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[33] A. Unlu,et al. Leptin and TNF-Alpha Levels in Patients with Chronic Obstructive Pulmonary Disease and Their Relationship to Nutritional Parameters , 2004, Respiration.
[34] H. Baker,et al. Molecular Characterization of the Acute Inflammatory Response to Infections with Gram-Negative versus Gram-Positive Bacteria , 2003, Infection and Immunity.
[35] E. Piitulainen,et al. Circulating monocytes from healthy individuals and COPD patients , 2003, Respiratory research.
[36] A. Lacy-Hulbert,et al. Apoptotic Cells and Innate Immune Stimuli Combine to Regulate Macrophage Cytokine Secretion 1 , 2003, The Journal of Immunology.
[37] P. Zimmerman,et al. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections , 2003, Genes and Immunity.
[38] L. Fabbri,et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. , 2003, Thorax.
[39] E. Rönmark,et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). , 2002, Respiratory medicine.
[40] Ash A. Alizadeh,et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[42] K. Wright,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[43] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.
[44] R. van Furth,et al. Anti-CD14 Monoclonal Antibodies Inhibit the Production of Tumor Necrosis Factor Alpha and Interleukin-10 by Human Monocytes Stimulated with Killed and Live Haemophilus influenzae or Streptococcus pneumoniaeOrganisms , 1999, Infection and Immunity.
[45] R. Rogers,et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.
[46] C. McCall,et al. Phagocytosis of Live Versus Heat-Killed Bacteria by Human Polymorphonuclear Leukocytes , 1974, Infection and immunity.